New York City, NY -- (SBWIRE) -- 12/26/2013 -- StockMarketIntel.com issues a special report on the following stocks: Bison Petroleum Corp (OTCMKTS:BISN), Transenterix Inc (OTCBB:TRXC), Advanced Cell Technology, Inc. (OTCMKTS:ACTC), Direct Insite Corporation (OTCMKTS:DIRI)
Bison Petroleum Corp (OTCMKTS:BISN) declined -16.50% recently, while trading on 149,314 shares at the price of $0.860. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.04 and was moved to its maximum level of $1.70.The stock changed hands in a range of $0.85 to $1.00, bringing its market capitalization at about $41.23 million. Bison Petroleum Corp. (Bison) is an independent American oil and gas company founded to provide the United States energy security by developing and producing oil and gas from the nation's energy heartlands. Bison's holdings are located in the Bighorn Basin, Wyoming.
Why Should Investors Buy BISN After the Recent Fall? Just Go Here and Find Out
Transenterix Inc (OTCBB:TRXC) declined -6.25% recently, in the current trading session, at $1.50 with a total volume of 23,100 shares. The stock, on average, trades on a volume of 36,735 shares. In the past 52 weeks, the share price has not declined below $0.22 and above $1.80.It floated in a range of $1.50 to $1.69 during the recent trading session, with a beta value of 2.45.Its market capitalization now moved to about $251.26 million. TransEnterix Inc, formerly SafeStitch Medical, Inc., is a developmental stage medical device company focused on the development of medical devices that manipulate tissues for the treatment of hernia formation, obesity, gastroesophageal reflux disease (GERD), esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery.
Will TRXC Get Buyers Even After The Recent Rally? Find Out Here
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) recently moving within a range of $0.06-$0.07. Its current trading price is $0.0615. The share price hit its 52-week low of $0.05 and $0.10 was the best price. The stock completed the day with a total volume of 2.61 million shares, versus an average volume of 4.28 million shares. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Can Investors Bet on ACTC after this News update? Find out in this Research Report
Direct Insite Corporation (OTCMKTS:DIRI) declined -2.40% in its current trading activity, bringing its market capitalization around $15.41 million. The total number of shares that changed hands during the current session up till now was 20,300 shares, as compared to average trading volume of 4,710 shares. The share price after opening at $1.05 made a high of $1.24 and hovered above $1.05, while its recent trading price was $1.22. Direct Insite Corp. (Direct Insite) operates as a software as a service provider (SaaS) providing financial supply chain automation and workflow efficiencies within the procure-to-pay (PTP) and order-to-cash (OTC) processes. The Company's global Electronic Invoice Presentment and Payment (EIP&P) services automate manual business processes such as complex billing, invoice validation, invoice-to-order matching, consolidation, dispute handling, and payment processing.
Will DIRI Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)